Cargando…

Executive Control of Attention in Narcolepsy

BACKGROUND: Narcolepsy with cataplexy (NC) is a disabling sleep disorder characterized by early loss of hypocretin neurons that project to areas involved in the attention network. We characterized the executive control of attention in drug-free patients with NC to determine whether the executive def...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bayard, Sophie, Croisier Langenier, Muriel, Cochen De Cock, Valérie, Scholz, Sabine, Dauvilliers, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338809/ https://www.ncbi.nlm.nih.gov/pubmed/22558075 http://dx.doi.org/10.1371/journal.pone.0033525

Ejemplares similares

Low Vitamin D in Narcolepsy with Cataplexy
por: Carlander, Bertrand, et al.
Publicado: (2011)

Daytime Sleepiness in Parkinson’s Disease: A Reappraisal
por: Cochen De Cock, Valérie, et al.
Publicado: (2014)

Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy
por: Deloumeau, Aude, et al.
Publicado: (2010)

Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy
por: Bayard, Sophie, et al.
Publicado: (2013)

Non-Dipping Blood Pressure Profile in Narcolepsy with Cataplexy
por: Dauvilliers, Yves, et al.
Publicado: (2012)

Recent advances in treatment for narcolepsy
por: Barateau, Lucie, et al.
Publicado: (2019)

Differences in Brain Morphological Findings between Narcolepsy with and without Cataplexy
por: Nakamura, Masaki, et al.
Publicado: (2013)

Gut microbiota composition is associated with narcolepsy type 1
por: Lecomte, Alexandre, et al.
Publicado: (2020)

Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy
por: Dauvilliers, Yves A., et al.
Publicado: (2014)

Histamine in murine narcolepsy: What do genetic and immune models tell us?
por: Melzi, Silvia, et al.
Publicado: (2021)

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy
por: Lopez, Régis, et al.
Publicado: (2017)

A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019)

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia
por: Dauvilliers, Yves, et al.
Publicado: (2017)

Clinical and polysomnographic course of childhood narcolepsy with cataplexy
por: Pizza, Fabio, et al.
Publicado: (2013)

Narcolepsy with cataplexy: Does age at diagnosis change the clinical picture?
por: Zhang, Min, et al.
Publicado: (2020)

Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
por: Watson, Nathaniel F., et al.
Publicado: (2021)

CSF and serum ferritin levels in narcolepsy type 1 comorbid with restless legs syndrome
por: Barateau, Lucie, et al.
Publicado: (2020)

High-dimensional single-cell analysis reveals the immune signature of narcolepsy
por: Hartmann, Felix J., et al.
Publicado: (2016)

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018)

Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
por: Dauvilliers, Yves, et al.
Publicado: (2019)

Complex movement disorders at disease onset in childhood narcolepsy with cataplexy
por: Plazzi, Giuseppe, et al.
Publicado: (2011)

Hypersomnia and depressive symptoms: methodological and clinical aspects
por: Dauvilliers, Yves, et al.
Publicado: (2013)

Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy
por: Stephansen, Jens B., et al.
Publicado: (2018)

Cerebrospinal fluid proteomics in recent-onset Narcolepsy type 1 reveals activation of the complement system
por: Ayoub, Ikram, et al.
Publicado: (2023)

Supramodal executive control of attention
por: Spagna, Alfredo, et al.
Publicado: (2015)

Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis
por: Dauvilliers, Y., et al.
Publicado: (2016)

Narcolepsy
por: Maclachlan, T. Kay
Publicado: (1930)

Narcolepsy
Publicado: (1929)

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
por: Ollila, Hanna M., et al.
Publicado: (2023)

Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy
por: Dauvilliers, Yves, et al.
Publicado: (2022)

Widespread Hypermetabolism in Symptomatic and Asymptomatic Episodes in Kleine-Levin Syndrome
por: Dauvilliers, Yves, et al.
Publicado: (2014)

Attention-Deficit/Hyperactivity Disorder Patients May Have Undiagnosed Narcolepsy
por: Wilenius, Lukas, et al.
Publicado: (2020)

Intellectual Abilities of Children with Narcolepsy
por: Thieux, Marine, et al.
Publicado: (2020)

Alerting, Orienting, and Executive Control: The Effect of Bilingualism and Age on the Subcomponents of Attention
por: Dash, Tanya, et al.
Publicado: (2019)

Genetics of narcolepsy
por: Miyagawa, Taku, et al.
Publicado: (2019)

Misdiagnosis of narcolepsy
por: Dunne, Laura, et al.
Publicado: (2016)

Idiopathic Narcolepsy
Publicado: (1927)

Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
por: Roth, Thomas, et al.
Publicado: (2022)

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
por: Evans, Rebecca, et al.
Publicado: (2022)

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial
por: Dauvilliers, Yves, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3qod6gglafb0cbteser0c1miv5